Unleashing Nature's potential: a computational approach to discovering novel VEGFR-2 inhibitors from African natural compound using virtual screening, ADMET …

S Baammi, A El Allali, R Daoud - Frontiers in Molecular Biosciences, 2023 - frontiersin.org
One of the characteristic features of cancer is angiogenesis, the process by which new,
aberrant blood vessels are formed from pre-existing blood vessels. The process of …

In Silico Discovery of Potential VEGFR-2 Inhibitors from Natural Derivatives for Anti-Angiogenesis Therapy

J Li, N Zhou, K Luo, W Zhang, X Li, C Wu… - International journal of …, 2014 - mdpi.com
Angiogenesis is the growth of new capillaries from existing blood vessels that supply oxygen
and nutrients and provide gateways for immune surveillance. Abnormal vessel growth in …

Virtual screening, molecular docking studies and DFT calculations of novel anticancer flavonoids as potential VEGFR-2 inhibitors

A Shah, G Parmar, U Shah, S Perumal - Chemistry Africa, 2023 - Springer
Angiogenesis is one of the hallmarks of cancer that helps in the development of new
abnormal blood vessels from preexisting blood vessels. The key aspect of targeting tumor …

Quantitative structure activity relationship and molecular simulations for the exploration of natural potent VEGFR-2 inhibitors: an in silico anti-angiogenic study

N Sharma, M Sharma, QI Rahman… - Journal of …, 2021 - Taylor & Francis
VEGFR-2 has recently become an eye-catching molecular target for the novel therapeutic
designs against cancer for its well known role in persuading angiogenesis in tumor cells …

Structure-based identification of potent VEGFR-2 inhibitors from in vivo metabolites of a herbal ingredient

R Dash, M Junaid, S Mitra, M Arifuzzaman… - Journal of molecular …, 2019 - Springer
Vascular endothelial growth factor receptor-2 (VEGFR-2) is one of the regulatory elements of
angiogenesis that is expressed highly in various diseases and is also essential for solid …

Molecular dynamics guided insight, binding free energy calculations and pharmacophore-based virtual screening for the identification of potential VEGFR2 inhibitors

E Rathi, A Kumar, SG Kini - Journal of Receptors and Signal …, 2019 - Taylor & Francis
Vascular endothelial growth factor-A (VEGF-A) is a crucial member of the Vascular
endothelial growth factor (VEGF) family which mediates the metastasis of tumor by …

The use of machine learning modeling, virtual screening, molecular docking, and molecular dynamics simulations to identify potential VEGFR2 kinase inhibitors

A Salimi, JH Lim, JH Jang, JY Lee - Scientific Reports, 2022 - nature.com
Targeting the signaling pathway of the Vascular endothelial growth factor receptor-2 is a
promising approach that has drawn attention in the quest to develop novel anti-cancer drugs …

Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular …

S Rampogu, A Baek, A Zeb, KW Lee - BMC cancer, 2018 - Springer
Background Angiogenesis is a process of formation of new blood vessels and is an
important criteria demonstrated by cancer cells. Over a period of time, these cancer cells …

[HTML][HTML] Development of newer generation Vascular endothelial growth factor Receptor-2 Inhibitors: Pharmacophore based design, virtual Screening, molecular …

MA Alamri, MM Alshahrani, AS Alawam, S Paria… - Journal of King Saud …, 2024 - Elsevier
Abstract Vascular Endothelial Growth Factor (VEGF) has a greater impact on
carcinogenesis, and it is the most significant receptor in mediating the mutagenesis and …

Computational investigation of 1, 3, 4 oxadiazole derivatives as lead inhibitors of VEGFR 2 in comparison with EGFR: Density functional theory, molecular docking and …

MS Bilal, SA Ejaz, S Zargar, N Akhtar, TA Wani, N Riaz… - Biomolecules, 2022 - mdpi.com
Vascular endothelial growth factor (VEGF) is an angiogenic factor involved in tumor growth
and metastasis. Gremlin has been proposed as a novel therapeutic pathway for the …